Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity?
2014 | journal article???letter_note???. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity?
Tzvetkov, M. V.; Seitz, T. ; Bokelmann, K.; Mueller, T.; Brockmoeller, J. & Koepsell, H. (2014)
Blood, 123(9) pp. 1427-1429. DOI: https://doi.org/10.1182/blood-2013-11-535864
